Type 1 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 1 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: Safety Study of Repeated Doses of Glucagon on Animal Starch in the Liver [NA]
A completed clinical trial assessing safety of repeated glucagon doses on liver tissue, with results posted in 2015.
-
CLINICAL_TRIALS research · 2015-04-27Clinical Trial Update: Continuous Glucose Sensing at the Site of Subcutaneous Insulin Administration [NA]
A clinical study evaluating continuous glucose sensing at the site of subcutaneous insulin administration has completed.
-
FDA approval · 2015-04-24FDA Approved: HUMALOG MIX75/25 — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humalog Mix75/25 (insulin lispro) from Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2015-04-24Clinical Trial Update: Pilot Study to Determine Effects of Salsalate in Type 1 Diabetes and Painful Peripheral Neuropathy [Phase 2]
Phase 2 pilot trial evaluating the effects of salsalate in individuals with Type 1 diabetes mellitus and peripheral neuropathy has completed…
-
CLINICAL_TRIALS trial_result · 2015-04-23Clinical Trial Update: Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus [Phase 3]
A Phase 3 trial compares a new formulation of insulin glargine with Lantus in patients with Type 1 diabetes; results have been posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-04-20FDA Approved: AFREZZA — Supplemental Application (Mannkind Corporation)
The FDA approved a supplemental application for AFREZZA (insulin human) submitted by MannKind Corporation.
-
FDA approval · 2015-04-17FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for NovoLog (insulin aspart) submitted by Novo Nordisk.
-
FDA approval · 2015-04-17FDA Approved: AFREZZA — Supplemental Application (Mannkind Corporation)
FDA approved a supplemental application for AFREZZA (insulin human) submitted by MannKind Corporation.
-
CLINICAL_TRIALS trial_result · 2015-04-17Clinical Trial Update: Effects of Vitamin D Supplementation in Subjects With New Onset of Type 1 Diabetes [Phase 4]
A Phase 4 clinical trial update examining the effects of vitamin D supplementation in individuals with new-onset Type 1 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2015-04-16Clinical Trial Update: MD-Logic Artificial Pancreas for Automatic Type 1 Diabetes Meals Management [NA]
This document notes that the MD-Logic Artificial Pancreas trial for automatic management of meals in Type 1 Diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Optimizing Closed-Loop Control of Type 1 Diabetes Mellitus in Adolescents [NA]
Clinical trial update on optimizing closed-loop control for Type 1 diabetes in adolescents; study completed with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-04-14Clinical Trial Update: Markers and Mechanisms of Macrovascular Disease in IDDM
A completed clinical trial investigated markers and mechanisms of macrovascular disease in individuals with insulin-dependent diabetes melli…
-
CLINICAL_TRIALS trial_result · 2015-04-14Clinical Trial Update: Insulin Sensitivity, Impaired Counterregulation, and Glucose Variability [NA]
A completed clinical trial investigating insulin sensitivity, impaired counterregulation, and glucose variability in Type 1 Diabetes. Result…
-
CLINICAL_TRIALS research · 2015-04-09Clinical Trial Update: A Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
A completed clinical trial update from Novo Nordisk describing a survey of hypoglycemia in insulin-treated patients with diabetes.
-
CLINICAL_TRIALS trial_result · 2015-04-09Clinical Trial Update: Neulasta in Type 1 Diabetes [Phase 1]
Phase 1 trial of Neulasta (pegfilgrastim) in individuals with Type 1 diabetes mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-08Clinical Trial Update: Empagliflozin add-on to Insulin in Type 1 Diabetes Mellitus Over 28 Days [Phase 2]
A Phase 2 trial evaluating empagliflozin added to insulin in adults with Type 1 diabetes mellitus over 28 days; results have been posted.
-
CLINICAL_TRIALS trial_result · 2015-04-07Clinical Trial Update: Incidence of Hypoglycemia During Ramadan in Patients With Type1 Diabetes on Insulin Pump Versus Multi Dose Injection
A completed clinical trial evaluating the incidence of hypoglycemia during Ramadan in people with Type 1 diabetes using insulin pumps compar…
-
CLINICAL_TRIALS withdrawal · 2015-04-02Clinical Trial Update: A Study to Evaluate a Multiple Model Probabilistic Predictive Controller (MMPPC) for Closed Loop Insulin Delivery [NA]
The clinical trial evaluating a multiple model probabilistic predictive controller for closed-loop insulin delivery in Type 1 Diabetes Melli…
-
CLINICAL_TRIALS trial_result · 2015-04-01Clinical Trial Update: Liraglutide as add-on to Insulin in Type 1 Diabetes [Phase 3]
A Phase 3 trial evaluating liraglutide as an add-on to insulin in Type 1 diabetes has completed.
-
CLINICAL_TRIALS withdrawal · 2015-04-01Clinical Trial Update: A Comparison of Strict Glucose Control With Usual Care at the Time of Islet Cell Transplantation [NA]
A clinical trial comparing strict glucose control with usual care during islet cell transplantation has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-03-25Clinical Trial Update: Milk as Treatment for Hypoglycemia [NA]
A clinical trial evaluating milk as a treatment for hypoglycemia in individuals with Type 1 diabetes mellitus has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Treatment of Low Blood Sugar With Glucagon Among Patients With Type 1 Diabetes [Phase 4]
A Phase 4 clinical trial update evaluating glucagon for treating hypoglycemia in people with Type 1 diabetes.
-
CLINICAL_TRIALS research · 2015-03-25Clinical Trial Update: Exercise in Type 1 Diabetes Mellitus [NA]
A completed clinical trial from Medical University of Graz evaluating blood glucose changes during and after defined individual exercise in …
-
FDA approval · 2015-03-20FDA Approved: SYMLINPEN — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for SYMLINPEN (pramlintide acetate) from AstraZeneca Pharmaceuticals LP.
-
CLINICAL_TRIALS trial_result · 2015-03-20Clinical Trial Update: EEG Changes of type1 Diabetes During Sleep -Insulin Induced Hypoglycemia
A completed clinical trial assessing EEG changes during sleep in individuals with Type 1 diabetes under insulin-induced hypoglycemia.